Candel Therapeutics Financial Overview
Candel Therapeutics's market cap is currently $333.78M. The company's EPS TTM is $-0.21; its P/E ratio is -10.87; Candel Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
